New York's highest court of appeals has held that no-fault insurers cannot deny no-fault benefits where they unilaterally determine that a provider has committed misconduct based upon alleged fraudulent conduct. The Court held that this authority belongs solely to state regulators, specifically New York's Board of Regents, which oversees professional licensing and discipline. This follows a similar recent ruling in Florida reported in this publication.
Ajay Goel, PhD, AGAF
Dr. Ajay Goel is a professor and chair of Department of Translational Genomics and Oncology at the Beckman Research Institute City of Hope Comprehensive Cancer Center, and director of Biotech Innovations at the City of Hope Medical Center, in Duarte, Calif. He has also been recognized as an American Gastrointestinal Association Fellow (AGAF) for his research on colorectal cancer. In fact, Dr. Goel has spent more than 20 years researching cancer and has been the lead author or contributor to over 300 scientific articles published in peer-reviewed international journals, as well as several book chapters. He is currently researching the prevention of GI cancers using integrative and alternative approaches, including botanical products. Three of the primary botanicals he is investigating are curcumin (from turmeric), boswellia and French grape seed. For inquiries regarding his research, contact him at ajgoel@coh.org.